About Index Trending news
Analyze
Pricing

Therapeutics

100+ Companies
Companies

Growing

169
Funding and Acquisitions

2017 Q1

27 + 1
Curators of Therapeutics
Xconomy

Neos Therapeutics’ Controlled-Release ADHD Drug Get FDA Approval

$50,000,000 Venture capital (Series D)
PE Hub

Omada Health reels in $50 mln

$2,100,000 Grant
Drug Delivery Business

Brainstorm lands $2.1m Israeli grant for NurOwn stem cell therapy

$15,000,000 Venture capital (Series G)
Twitter , FinSMEs , prnewswire

NeuroBrain on Twitter

Xconomy

RNA Specialist Arcturus Therapeutics Gets $3M R&D Grant for CF Drug

$65,000,000 Venture capital (Series B)
PE Hub

Iterum grabs $65 mln Series B

Venture capital
Benzinga

Enterprise Therapeutics receives funding from Cystic Fibrosis Trust

$18,400,000 Venture capital (Series B)
FierceBiotech

Viracta nabs $18.4M, Soon-Shiong as vice chair in Series B

$75,000,000 IPO
Xconomy

With $75M Haul, Ovid Continues Flurry of Biotech IPOs

$3,700,000 Venture capital (Series A)
PE Hub

Lantern Pharma rallies $3.7 mln Series A

$15,000,000 Debt financing
texastechpulse

Savara Gets $15M In Debt Funding From SVB

$6,900,000 Grant
biospace , businesswire

Cidara Awarded 6 9 Million Grant From CARB X To Advance Development Of Its First Cloudbreak Antibiotic Immunotherapy

$6,500,000 Venture capital (Series A)
PE Hub

Circle Pharma racks up about $6.5 mln

$9,000,000 Post-IPO equity
Drug Delivery Business

DelMar closes $9m public offering

Xconomy

Bristol Flips Remnants of Adnexus, iPierian to Roche, Biogen For $470M

$40,000,000 Venture capital (Series A)
PE Hub , Xconomy

Cirius Therapeutics nets $40 mln

Data leaks Funding Strategy
FinSMEs

BaseLaunch Accelerator Just Started Its Search for Finding Groundbreaking Healthcare Ventures

$433,000 Grant
GEN

Inhibikase Wins $433,000 MJFF Grant to Study c-Abl Inhibitors as Parkinson's Treatment Genetic Engineering & Biotechnology News - Biotech from Bench to Business

$225,000 Grant
texastechpulse

CerSci Therapeutics Finds $225,000 From SBIR Grant

$55,000,000 Venture capital (Series A)
businesswire

Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment